Everolimus improved PFS in patients with metastatic, ER-positive breast cancer
SAN ANTONIO — Adding everolimus to exemestane in postmenopausal patients with ER-positive advanced breast cancer improved PFS, according to research presented here. Study researcher Gabriel N. Hortobagyi, MD, FACP, professor of medicine and chair of ...
SABCS: Breast Cancer Survival Up With Everolimus + Exemestane
SABCS: Addition of Everolimus Helps Slow Breast Cancer
BOLERO-2: Everolimus Plus Exemestane Delays Breast Cancer Progression